Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Verna Cheung

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
American Journal of Hematology|January 24, 2023
Screening for signs of portal hypertension by esophagogastroduodenoscopy in patients with BCR-ABL negative myeloproliferative neoplasmsMarta Davidson, Florence Wong, Mostafa Atri, et al.
Canadian Oncology Nursing Journal = Revue Canadienne De Nursing Oncologique|August 28, 2025
Verna Cheung, Melanie Powis, Jaime O Claudio, et al.
Canadian Oncology Nursing Journal = Revue Canadienne De Nursing Oncologique|August 28, 2025
Impact of the clinical nurse specialist role for the myeloproliferative neoplasm program: Part One - From timeliness of triage to cost-savingVerna Cheung, Melanie Powis, Jaime O Claudio, et al.
Canadian Oncology Nursing Journal = Revue Canadienne De Nursing Oncologique|September 2, 2025
Impact of the clinical nurse specialist role for the myeloproliferative neoplasm program: Part Two - The team and patient care experiencesVerna Cheung, Melanie Powis, Jaime O Claudio, et al.
American Journal of Hematology|February 23, 2023
Comparison of clinical outcomes between transplant and nontransplant therapies in myelofibrosis following failure of first-line JAK-inhibitorJames T England, Eshetu G Atenafu, James A Kennedy, et al.
British Journal of Haematology|June 16, 2021
Association of frailty with clinical outcomes in myelofibrosis: a retrospective cohort studyAniket Bankar, Shabbir Alibhai, Elliot Smith, et al.
Leukemia|March 29, 2022
Clinical and molecular correlates of JAK-inhibitor therapy failure in myelofibrosis: long-term data from a molecularly annotated cohortJames T England, Caroline J McNamara, James A Kennedy, et al.
Transplantation and Cellular Therapy|April 2, 2021
Association of Factors Influencing Selection of Upfront Hematopoietic Cell Transplantation versus Nontransplantation Therapies in MyelofibrosisElliot Smith, Jingyue Huang, Auro Viswabandya, et al.
Blood Advances|January 3, 2024
Outcomes of intensive and nonintensive blast-reduction strategies in accelerated and blast-phase MPNMarta B Davidson, James A Kennedy, Jose-Mario Capo-Chichi, et al.
Leukemia|February 6, 2024
Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group StudyJames T England, Natasha Szuber, Shireen Sirhan, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
American Journal of Hematology|January 24, 2023
Screening for signs of portal hypertension by esophagogastroduodenoscopy in patients with BCR-ABL negative myeloproliferative neoplasmsMarta Davidson, Florence Wong, Mostafa Atri, et al.
Canadian Oncology Nursing Journal = Revue Canadienne De Nursing Oncologique|August 28, 2025
Verna Cheung, Melanie Powis, Jaime O Claudio, et al.
Canadian Oncology Nursing Journal = Revue Canadienne De Nursing Oncologique|August 28, 2025
Impact of the clinical nurse specialist role for the myeloproliferative neoplasm program: Part One - From timeliness of triage to cost-savingVerna Cheung, Melanie Powis, Jaime O Claudio, et al.
Canadian Oncology Nursing Journal = Revue Canadienne De Nursing Oncologique|September 2, 2025
Impact of the clinical nurse specialist role for the myeloproliferative neoplasm program: Part Two - The team and patient care experiencesVerna Cheung, Melanie Powis, Jaime O Claudio, et al.
American Journal of Hematology|February 23, 2023
Comparison of clinical outcomes between transplant and nontransplant therapies in myelofibrosis following failure of first-line JAK-inhibitorJames T England, Eshetu G Atenafu, James A Kennedy, et al.
British Journal of Haematology|June 16, 2021
Association of frailty with clinical outcomes in myelofibrosis: a retrospective cohort studyAniket Bankar, Shabbir Alibhai, Elliot Smith, et al.
Leukemia|March 29, 2022
Clinical and molecular correlates of JAK-inhibitor therapy failure in myelofibrosis: long-term data from a molecularly annotated cohortJames T England, Caroline J McNamara, James A Kennedy, et al.
Transplantation and Cellular Therapy|April 2, 2021
Association of Factors Influencing Selection of Upfront Hematopoietic Cell Transplantation versus Nontransplantation Therapies in MyelofibrosisElliot Smith, Jingyue Huang, Auro Viswabandya, et al.
Blood Advances|January 3, 2024
Outcomes of intensive and nonintensive blast-reduction strategies in accelerated and blast-phase MPNMarta B Davidson, James A Kennedy, Jose-Mario Capo-Chichi, et al.
Leukemia|February 6, 2024
Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group StudyJames T England, Natasha Szuber, Shireen Sirhan, et al.
Pageof 2